Zoetis inc stock.
Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing. tendered in exchange for 400,985,000 shares of common stock of Zoetis Inc. (“Zoetis”), representing all of the Zoetis stock then owned by Pfizer (the “Exchange”). Pursuant to the Exchange, tendering Pfizer shareholders received 0.9898 of a share of Zoetis common stock in exchange for each share of PfizerMar 1, 2023 · Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ... Zoetis Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ZTS updated stock price target summary.Stock buybacks reduce the number of shares outstanding, so the remaining shareholders receive. ... Zoetis Inc. (ZTS) Shareholder Yield . 2.5%. Forward 5-Year Annual EPS Estimate +15.6%.
The estimated Net Worth of Paul Bisaro is at least $38.1 million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.
The estimated Net Worth of Kristin C Peck is at least $40.1 Million dollars as of 11 February 2023. Ms. Peck owns over 29,984 units of Zoetis Inc stock worth over $11,181,731 and over the last 11 years she sold ZTS stock worth over $25,559,608. In addition, she makes $3,330,160 as Chief Executive Officer und Director at Zoetis Inc.
Mr. Steere ZTS stock SEC Form 4 insiders trading. William has made over 4 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 16,170 units of ZTS stock worth $2,861,605 on 20 May 2021.. The largest trade he's ever made was exercising 16,170 units of Zoetis Inc stock on 20 May …Feb 15, 2023 · Zoetis shares rose 5.4% on Tuesday after Q4 2022 results showed its growth back on track. The P/E is now back to 35x. See why ZTS stock is a buy. In the previous week, Boston Scientific had 6 more articles in the media than Zoetis. MarketBeat recorded 12 mentions for Boston Scientific and 6 mentions for Zoetis. Boston Scientific's average media sentiment score of 1.32 beat Zoetis' score of 0.64 indicating that Zoetis is being referred to more favorably in the news media.Net Income Attributable to Zoetis $ 1,638 $ 2,037 $ 2,114 Adjusted Net Income Attributable to Zoetis† $ 1,844 $ 2,240 $ 2,297 Diluted Earnings Per Share $ 3.42 $ 4.27 $ 4.49 Adjusted ... of-stock situations. Across our global manufacturing and supply network of 29 sites, we are deploying the technology,
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Is Zoetis Inc worth watching? 12 stock analysts on Stockchase covered Zoetis Inc In the last year. It is a trending stock that is worth watching. What is Zoetis Inc ...
On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the "Company"), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr.Nov 29, 2023 · Zoetis (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis | Nyse: ZTS | Nyse Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement.74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Zoetis Inc. (ZTS) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 179.13 +2.46 (+1.39%) At close: 04:00PM EST 180.00... 175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 …The estimated Net Worth of Paul Bisaro is at least $38.1 millió dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.
Compare ZTS With Other Stocks. Sector, Industry, Market Cap, Revenue. Medical · Medical - Drug Manufacturing, $81.112B, $8.080B. Zoetis Inc. is a leader in the ...Nov 13, 2023 · Zoetis Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Mexican Stock Exchange: ZTS ... 0.92%. $5.88B. ZTS | Complete Zoetis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ZTS - Zoetis Inc - Stock screener for investors and traders, financial visualizations. ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation.May 25, 2023 · PARSIPPANY, N.J., May 25, 2023--Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ...
PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021. The company reported revenue of $2.0 billion for the third quarter of 2021, an increase of 11% compared with the third quarter of 2020.
2 nov 2023 ... Some better-ranked stocks in the healthcare sector are Dynavax Technologies Corporation ( DVAX Quick Quote DVAX - Free Report) , MEI Pharma, Inc ...Michael has made over 37 trades of the Zoetis Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 1,626 units of ZTS stock worth $287,623 on 11 February 2023.WELCOME TO ZOETIS. We are a global team committed to nurturing the world and humankind by advancing care for animals. For nearly 70 years, Zoetis has worked shoulder to shoulder with those who raise and care for animals, from veterinary clinics, homes and farms. With our R&D technical and manufacturing experience, we create innovative and ...Jamie Brannan ZTS stock SEC Form 4 insiders trading. Jamie has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Jamie exercised 391 units of ZTS stock worth $66,716 on 11 February 2023.. The largest trade Jamie's ever made was exercising 391 units of Zoetis Inc stock …Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Nov 28, 2023 · On Monday, Zoetis Inc [NYSE:ZTS] saw its stock fall -0.79% to $178.79. On the same session, the stock had its day’s lowest price of $178.47, but rose to a high of $180.79. Over the last five days, the stock has gained 2.28%. Zoetis Inc shares have risen nearly 22.00% since the year began. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Nov 11, 2022 · Zoetis has repurchased $545m of its stock in Q1-3, equivalent to 0.8% of its current market capitalization. Out of a $3.5bn share repurchase program authorized in December 2021, $3.0bn remained at ...
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats ...
Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ...
Zoetis Inc. (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Nyse: ZTS | NyseThe company reported revenue of $2.0 billion for the third quarter of 2022, an increase of 1% compared with the third quarter of 2021. Net income for the third quarter of 2022 was $529 million, or $1.13 per diluted share, a decrease of 4% and 3%, respectively, on a reported basis. On an operational 1 basis, revenue for the third quarter of 2022 ...The estimated Net Worth of William C Jr Steere is at least $6.34 millió dollars as of 20 May 2021. Mr. Steere owns over 16,170 units of Zoetis Inc stock worth over $6,013,788 and over the last 20 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc.The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the third quarter of 2023. The dividend will be paid on Friday, September 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, July 21, 2023.Zoetis Inc. (ZTS) Stock Data. Avg Price Recovery. 2.4 Days. Best dividend capture stocks in Dec. Payout Ratio (FWD) 24.92%. Years of Dividend Increase.Zoetis Inc. (ZTS) Stock Price | Stock Quote Nyse - MarketScreener ZOETIS INC. Zoetis Inc. Stock price Equities ZTS US98978V1035 Pharmaceuticals …Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.LOS ANGELES, October 6, 2023 - Basepaws, the leader in feline DNA testing and genetics, enters the canine market with the most extensive DNA test for dogs, accelerating the health genetic testing landscape.Basepaws Breed + Health Dog DNA Test helps pet owners shift from reactive to proactive care, offering easy swabbing and mobile-friendly results for a …Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ...13 abr 2023 ... Zoetis Inc. (ZTS) develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States ...See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
The estimated Net Worth of Gregory Norden is at least $5.83 Million dollars as of 7 March 2023. Mr. Norden owns over 12,500 units of Zoetis Inc stock worth over $4,114,068 and over the last 10 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ... Zoetis Inc. is a global leader in the discovery, development, ... we get an intrinsic value of $129.09 for Zoetis. This makes the stock still overvalued at this point. Conclusion.Instagram:https://instagram. xomo dividendhow to buy mortgage backed securitiesjepi stock dividend yieldtesla model 3 incentives Animal health company Zoetis Inc. ( NYSE: ZTS) traded higher Friday as analysts commented on the FDA approval of German drugmaker Boehringer Ingelheim's parasiticide NexGard Plus for dogs. The ...Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ... paper trading websitenasdaq lcid compare What ETF is ZOETIS INC in? Information about cost, fund size and performance of the ETFs that contain this stock.Our Story. At Zoetis, our purpose is to nurture our world and humankind by advancing care for animals. It’s an ambitious and humbling pursuit, but with a diverse and talented team supporting our customers all around the world, we’ve experienced 70+ years of success in animal health. Play the video. Home → Our Company → History. is masseter botox covered by insurance Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing. 04/05/2023. Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being. 03/30/2023. Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results. 03/13/2023. Zoetis Named One of the World’s Most Ethical Companies by Ethisphere.Nov 11, 2022 · Zoetis has repurchased $545m of its stock in Q1-3, equivalent to 0.8% of its current market capitalization. Out of a $3.5bn share repurchase program authorized in December 2021, $3.0bn remained at ...